Rod-shaped micropatterning enhances the electrophysiological maturation of cardiomyocytes derived from human induced pluripotent stem cells.


Journal

Stem cell reports
ISSN: 2213-6711
Titre abrégé: Stem Cell Reports
Pays: United States
ID NLM: 101611300

Informations de publication

Date de publication:
16 Sep 2024
Historique:
received: 02 10 2023
revised: 20 08 2024
accepted: 20 08 2024
medline: 21 9 2024
pubmed: 21 9 2024
entrez: 20 9 2024
Statut: aheadofprint

Résumé

Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) offer great potential for drug screening and disease modeling. However, hiPSC-CMs remain immature compared to the adult cardiac cells. Cardiomyocytes isolated from adult human hearts have a typical rod-shaped morphology. Here, we sought to develop a simple method to improve the architectural maturity of hiPSC-CMs by using a rod-shaped cell micropatterned substrate consisting of repeated rectangles (120 μm long × 30 μm wide) surrounded by a chemical cell repellent. The generated hiPSC-CMs exhibit numerous characteristics similar to adult human cardiomyocytes, including elongated cell shape, well-organized sarcomeres, and increased myofibril density. The improvement in structural properties correlates with the enrichment of late ventricular action potentials characterized by a more hyperpolarized resting membrane potential and an enhanced depolarization consistent with an increased sodium current density. The more mature hiPSC-CMs generated by this method may serve as a useful in vitro platform for characterizing cardiovascular disease.

Identifiants

pubmed: 39303707
pii: S2213-6711(24)00243-1
doi: 10.1016/j.stemcr.2024.08.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests J.-S.H. reports research grants from Sanofi and Pliant Therapeutics unrelated to the present work and speaker, advisory board, or consultancy fees from Alnylam, Amgen, AstraZeneca, Bayer Pharma, BioSerenity, Boehringer Ingelheim, Bristol-Myers Squibb, Novartis, Novo Nordisk, and Vifor Pharma all unrelated to the present work. The rod-shaped cell micropatterned substrate is marketed by 4DCell (Montreuil, France).

Auteurs

Zeina R Al Sayed (ZR)

Université de Paris Cité, PARCC, INSERM, 75006 Paris, France.

Charlène Jouve (C)

Université de Paris Cité, PARCC, INSERM, 75006 Paris, France.

Magali Seguret (M)

Université de Paris Cité, PARCC, INSERM, 75006 Paris, France.

Andrea Ruiz-Velasco (A)

Université de Paris Cité, PARCC, INSERM, 75006 Paris, France.

Céline Pereira (C)

Université de Paris Cité, PARCC, INSERM, 75006 Paris, France.

David-Alexandre Trégouët (DA)

INSERM UMR_S 1219, Bordeaux Population Health Research Center, University of Bordeaux, Bordeaux, France.

Jean-Sébastien Hulot (JS)

Université de Paris Cité, PARCC, INSERM, 75006 Paris, France; CIC1418 and DMU CARTE, AP-HP, Hôpital Européen Georges-Pompidou, 75015 Paris, France. Electronic address: jean-sebastien.hulot@inserm.fr.

Classifications MeSH